Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) — Strategic Asset Allocation Index
Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) has a Strategic Asset Allocation Index of 43.1% as of June 2023. Strategic assets (PP&E of CN¥808.86 Million plus long-term investments of CN¥-) total CN¥808.86 Million, measured against net assets of CN¥1.88 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300501 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 43.1%, representing strategic assets of CN¥808.86 Million against net assets of CN¥1.88 Billion CNY. For live market cap and overall valuation, see Shanghai Haishun New Pharmaceutical Pack market cap and net worth.
Annual Strategic Asset Allocation Index for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 300501 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.3% | CN¥744.48 Million | CN¥744.48 Million | CN¥- | CN¥1.68 Billion | ▲ +1.8 pp |
| 2021 | 42.5% | CN¥674.09 Million | CN¥674.09 Million | CN¥- | CN¥1.59 Billion | ▼ -12.4 pp |
| 2020 | 54.9% | CN¥481.29 Million | CN¥481.29 Million | CN¥- | CN¥876.40 Million | ▲ +11.1 pp |
| 2019 | 43.8% | CN¥334.18 Million | CN¥334.18 Million | CN¥- | CN¥762.37 Million | ▲ +0.6 pp |
| 2018 | 43.3% | CN¥309.29 Million | CN¥308.80 Million | CN¥482.61K | CN¥714.84 Million | ▲ +13.7 pp |
| 2017 | 29.6% | CN¥187.56 Million | CN¥187.56 Million | CN¥- | CN¥633.69 Million | ▲ +6.4 pp |
| 2016 | 23.2% | CN¥138.10 Million | CN¥138.10 Million | CN¥- | CN¥594.42 Million | ▼ -6.0 pp |
| 2015 | 29.3% | CN¥79.32 Million | CN¥79.32 Million | CN¥- | CN¥270.92 Million | ▼ -2.6 pp |
| 2014 | 31.9% | CN¥73.96 Million | CN¥73.96 Million | CN¥- | CN¥232.14 Million | ▼ -8.8 pp |
| 2013 | 40.7% | CN¥79.66 Million | CN¥79.66 Million | CN¥- | CN¥195.85 Million | ▼ -4.1 pp |
| 2012 | 44.8% | CN¥73.88 Million | CN¥73.88 Million | CN¥- | CN¥164.87 Million | ▼ -8.3 pp |
| 2011 | 53.1% | CN¥69.51 Million | CN¥69.51 Million | CN¥- | CN¥130.81 Million | — |